These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24303922)

  • 21. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
    Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G
    Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas.
    Gong J; Chen N; Zhou Q; Yang B; Wang Y; Wang X
    J Clin Pathol; 2005 Oct; 58(10):1081-5. PubMed ID: 16189155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
    Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
    Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of human melanoma growth and metastasis by AGE-AGE receptor interactions.
    Abe R; Shimizu T; Sugawara H; Watanabe H; Nakamura H; Choei H; Sasaki N; Yamagishi S; Takeuchi M; Shimizu H
    J Invest Dermatol; 2004 Feb; 122(2):461-7. PubMed ID: 15009731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E-cadherin/catenin complex in benign and malignant melanocytic lesions.
    Silye R; Karayiannakis AJ; Syrigos KN; Poole S; van Noorden S; Batchelor W; Regele H; Sega W; Boesmueller H; Krausz T; Pignatelli M
    J Pathol; 1998 Dec; 186(4):350-5. PubMed ID: 10209482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.
    Abdou AG; Maraee AH; El-Sayed EM; Elnaidany NF
    Ann Diagn Pathol; 2011 Dec; 15(6):394-401. PubMed ID: 21849257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the Ca2+ -regulated ezrin-S100P interaction and its role in tumor cell migration.
    Austermann J; Nazmi AR; Müller-Tidow C; Gerke V
    J Biol Chem; 2008 Oct; 283(43):29331-40. PubMed ID: 18725408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between S100P and the anti-allergy drug cromolyn.
    Penumutchu SR; Chou RH; Yu C
    Biochem Biophys Res Commun; 2014 Nov; 454(3):404-9. PubMed ID: 25450399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms.
    Cohn ML; Goncharuk VN; Diwan AH; Zhang PS; Shen SS; Prieto VG
    J Cutan Pathol; 2005 Sep; 32(8):533-6. PubMed ID: 16115050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA; Guitart J; Rao MS; Diaz LK
    Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcium-Bound S100P Protein Is a Promiscuous Binding Partner of the Four-Helical Cytokines.
    Kazakov AS; Deryusheva EI; Permyakova ME; Sokolov AS; Rastrygina VA; Uversky VN; Permyakov EA; Permyakov SE
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-Akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions.
    Shanesmith RP; Smart C; Cassarino DS
    Am J Dermatopathol; 2011 Oct; 33(7):663-8. PubMed ID: 21915031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In situ expression patterns of melanoma-inhibiting activity (MIA) in melanomas and breast cancers.
    Bosserhoff AK; Moser M; Hein R; Landthaler M; Buettner R
    J Pathol; 1999 Mar; 187(4):446-54. PubMed ID: 10398105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RAGE and S100 protein transcription levels are highly variable in human melanoma tumors and cells.
    Leclerc E; Heizmann CW; Vetter SW
    Gen Physiol Biophys; 2009; 28 Spec No Focus():F65-75. PubMed ID: 20093728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular regulation of S100P in human lung adenocarcinomas.
    Rehbein G; Simm A; Hofmann HS; Silber RE; Bartling B
    Int J Mol Med; 2008 Jul; 22(1):69-77. PubMed ID: 18575778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pleiotropic function of ezrin in human metastatic melanomas.
    Federici C; Brambilla D; Lozupone F; Matarrese P; de Milito A; Lugini L; Iessi E; Cecchetti S; Marino M; Perdicchio M; Logozzi M; Spada M; Malorni W; Fais S
    Int J Cancer; 2009 Jun; 124(12):2804-12. PubMed ID: 19235924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ezrin interacts with the scaffold protein IQGAP1 and affects its cortical localization.
    Nammalwar RC; Heil A; Gerke V
    Biochim Biophys Acta; 2015 Sep; 1853(9):2086-94. PubMed ID: 25554515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Different expression of lysosome-associated membrane protein-1 in human melanomas and benign melanocytic lesions.
    Kuźbicki L; Gajo B; Chwirot BW
    Melanoma Res; 2006 Jun; 16(3):235-43. PubMed ID: 16718270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cadherin expression in melanocytic naevi and malignant melanomas.
    Cowley GP; Smith ME
    J Pathol; 1996 Jun; 179(2):183-7. PubMed ID: 8758211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of neurotrophins and their receptors in pigment cell lesions of the skin.
    Innominato PF; Libbrecht L; van den Oord JJ
    J Pathol; 2001 May; 194(1):95-100. PubMed ID: 11329147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.